Clinical trial

A Study of GZR18 Tablet in Chinese Healthy Subjects

NCT06554054

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-04-01

PhasePHASE1

Study timeline

Study start (actual)2024-04-01Date precision: day

Registry last updated2024-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

GZR18DRUG

Sponsors & collaborators

Gan and Lee Pharmaceuticals, USAlead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06554054 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.